Global Statistics Representing Oncology Information System Market Scenario
In the last century, maintaining profiles and treatment information of a cancer patient was a tedious task. However, it has become relatively easy with several technological advancements. For instance, modern technology of Oncology information system (OIS) is used for the accurate recording of all the information of a cancer patient. Increasing environmental pollution and changing lifestyle have significantly spurred the prevalence of blood cancer, lung cancer, colorectal cancer, prostate cancer, breast cancer, and cervical cancer, among others. According to the WHO, over 8 million people died of cancer globally in 2015. Moreover, a study suggests that 75% of the global geriatric population is at a high risk of developing different types of cancers. Currently, the developing countries are housing the highest geriatric and cancer population.
Global oncology information system market was valued at USD 2,717 million in 2018 and is expected to grow at a CAGR of 7.7 % during the forecast period 2019–2026.
Global oncology information system market is segmented by products and services, application, and end users.
By products and services, the global oncology information system market is segmented into software and professional services. The software segment is holding the largest market share. As the number of cancer patients is rising at an alarming rate, maintaining patients’ data has become essential. To attend to this concern, several players are taking efforts for introducing various technologically advanced software with innovative features like appointment management, billing management, clinical workflow, document management, medical templates, patient demographics, and patient portal.
Based on the application, the market is segmented into medical oncology, radiation oncology, and surgical oncology. The medical oncology is expected to witness the fastest growth in the years to come. The India and China OIS market is experiencing a stable growth on account of swelling demand for effective treatment. Currently, medical oncology has become one of the safest and most effective methods for treating cancer. Numerous players are actively focusing on introducing innovative medical oncology treatment options to the market as a result a number of drugs are currently in pipeline, which are likely to influence the demand for oncology information system. In 2017, RaySearch launched RayCare an oncology information system to connect different oncology disciplines.
By end user, the oncology information system market is segmented into hospitals & physician's offices, governmental institutions, and research centers.
Geographically, the global oncology information system market is segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA).
Rising prevalence of cancer in the Americas is increasing the adoption of OIS. In 2015, approximately 1,762,450 new cases of cancer were diagnosed in the U.S. alone. Additionally, over 7,210 people died of melanoma in 2019. In line with, the U.S. government has incorporated oncology information system in their healthcare sectors to provide better and effective treatment for cancer. Moving further, the American Cancer Society Inc, National Cancer Institute, and American Children Association have also organized various cancer educating programs to spread awareness among people regarding effective treatment options. They have also invested a huge sum in the R&D activities to develop better treatment options. In addition, presence of various organization, research centers, and multispecialty cancer hospital across the Americas is flourishing the demand for oncology information system.
Globally, Europe is the second leading oncology information system market as the region is housing a huge cancer population, for instance, over 55213 new breast cancer cases were diagnosed in 2016. To attend the concern, the governments and non-profit organizations in the region are heavily investing to improve healthcare infrastructure, multispecialty hospital, and research centers. Recently, CDC has invested over USD 498.8 in the cancer research. To make widespread availability of advanced cancer treatments in Europe, various market players are also collaborating and acquiring other firms such as the U.K Department of Health, the Welcome Trust, the National Health Service, NICE, and the National Cancer Intelligence Network have collaborated with National Cancer Research Institute and Medical Research Council (U.K).
Our Report Covers
Some of the major players in the global oncology information system market are Bogardus Medical Systems, Inc.(U.S.), Charm Health(Austrelia), Accuray Incorporated(U.S.), Siemens Healthcare(Germany), Elekta AB(Sweden), CureMD Corporation(U.S.), Cerner Corporation(U.S.), Flatiron Health, Inc.(U.S.), Epic Systems Corporation(U.S.), McKesson Corporation(U.S.), Bizmatics, Inc.(U.S.), RaySearch Laboratories AB(Sweden), Koninklijke Philips N.V.( Netherlands), Cordata Healthcare Innovations LLC(U.S.),, Varian Medical Systems, Inc.(U.S.), and IMPAC Medical Systems, Inc.(U.S.)
Oncology Information System Market Segmentation
By Products and Services
By End User
o North America
o South America
o Western Europe
Rest of Western Europe
o Eastern Europe
o South Korea
o Rest of Asia Pacific
The Middle East & Africa
o The Middle East
Rest of the Middle East